참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2-Chloropyridine | HCID 7977 | — |
| 반응물 | 2-Aminooxazole | HCID 558521 | — |
| 시약 | Cesium carbonate | HCID 10796 | — |
| 촉매 | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| 촉매 | Palladium (II) acetate | HCID 4144353 | — |
| 용매 | 1,4-Dioxane | HCID 31275 | — |
| 생성물 | N-pyridin-2-yl-1,3-oxazol-2-amine | HCID 67636727 | 0% |
반응 단계
Palladium(II) acetate (4.49 mg, 0.02 mmol) and 9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene (0.017 g, 0.03 mmol) were mixed together in a reaction vessel and evacuated and purged with nitrogen 3 times. Dioxane (1 mL) was added and the resulting mixture was heated to to 50°C for 30 minutes. oxazol-2-amine (0.101 g, 1.20 mmol) together with 2-chloropyridine (0.094 mL, 1.00 mmol) and cesium carbonate (0.456 g, 1.40 mmol) were placed in a second vessel, evacuated and purged with nitrogen 3 times and dioxane (3 mL) was added. The catalyst solution was added and the resulting mixture heated at 100 °C for 16 hours. **No oxazol-2-amine present in proton NMR of crude reaction mixture.** The starting material is decomposing under the reaction conditions, could be the route of the very low productivity in the C-N couplings using these substrates. Only chloropyridine observed in the proton NMR and LCMS of the crude reaction mixture. Conclusion: Experiment abandoned, none of the desired product isolated. .
출처 및 근거
| 출처 데이터셋 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-cdacdc2f62e2433897c344ea48603986 |
|---|
| 출처 메모 | 750 AstraZeneca ELN dataset |
|---|